These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


313 related items for PubMed ID: 9846248

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P, Grimm G.
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H, Solere M, Granier P, Cauvet G, Bali JP, Pons F, Bellet-Hermann H.
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [Abstract] [Full Text] [Related]

  • 27. Treatment of mastalgia with tamoxifen in male patients with liver cirrhosis: a randomized crossover study.
    Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Kuo BI, Chu CJ, Lee SD.
    Am J Gastroenterol; 2000 Apr; 95(4):1051-5. PubMed ID: 10763958
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G, García de León M, de la Torre Gutiérrez S, Montero Vázquez J, Torres Salcines J, de la Torre Fernández JM.
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics.
    Rogers JF, Morrison AL, Nafziger AN, Jones CL, Rocci ML, Bertino JS.
    Clin Pharmacol Ther; 2002 Dec; 72(6):711-7. PubMed ID: 12496752
    [Abstract] [Full Text] [Related]

  • 33. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma.
    Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF.
    Neurochem Int; 2006 Sep; 49(4):372-8. PubMed ID: 16563564
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study.
    Höjer J, Baehrendtz S, Matell G, Gustafsson LL.
    BMJ; 1990 Dec 08; 301(6764):1308-11. PubMed ID: 1980218
    [Abstract] [Full Text] [Related]

  • 35. Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients.
    Weinbroum A, Rudick V, Sorkine P, Nevo Y, Halpern P, Geller E, Niv D.
    Crit Care Med; 1996 Feb 08; 24(2):199-206. PubMed ID: 8605789
    [Abstract] [Full Text] [Related]

  • 36. Pathophysiology of hepatic encephalopathy: studies in autopsied brain tissue from hepatic coma patients.
    Butterworth RF.
    Rev Invest Clin; 1990 Jul 08; 42 Suppl():131-6. PubMed ID: 19256152
    [Abstract] [Full Text] [Related]

  • 37. Flumazenil for hepatic coma: the elusive wake-up call?
    Sterling RK, Shiffman ML, Schubert ML.
    Gastroenterology; 1994 Oct 08; 107(4):1204-5. PubMed ID: 7926473
    [No Abstract] [Full Text] [Related]

  • 38. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 08; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 39. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 08; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 40. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH, Tiller J, Xie F, Trivedi MH.
    J Clin Psychopharmacol; 2008 Jun 08; 28(3):308-16. PubMed ID: 18480688
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.